Pharming Group N.V. (PHAR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$15.38
Day's range
$16.14

Pharming Group N.V. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC 01/12/2026 50.55 K $893.17 K   -3.07% 0.08%
NEWEDGE ADVISORS, LLC 02/18/2026 28.87 K $510.10 K   11,310.28% 0.04%
MILLENNIUM MANAGEMENT LLC 02/17/2026 20.39 K $360.20 K   100.00% 0.03%
CITADEL ADVISORS LLC 02/17/2026 17.69 K $312.58 K   100.00% 0.03%
02/12/2026 12.69 K $224.18 K   100.00% 0.02%
MORGAN STANLEY 02/13/2026 7.70 K $136.06 K   76.81% 0.01%
EVERSOURCE WEALTH ADVISORS, LLC 02/06/2026 904 $15.97 K   -34.35% 0.00%
NALLS SHERBAKOFF GROUP, LLC 03/12/2026 870 $15.37 K   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 800 $14.14 K   700.00% 0.00%
UBS GROUP AG 01/29/2026 1 $18   100.00% 0.00%
GLOBAL RETIREMENT PARTNERS, LLC 02/06/2026 0 $0   -100.00% 0.00%
SBI SECURITIES CO., LTD. 02/03/2026 0 $0   -100.00% 0.00%

Pharming Group N.V. institutional Ownership - FAQ's

During the previous two years, 13 institutional investors and hedge funds held shares of Pharming Group N.V.. The most heavily invested institutionals were:

Silverberg Bernstein Capital Management LLC: 44,747

Stone House Investment Management, LLC: 79

UBS Group AG: 0

NewEdge Advisors, LLC: 28,868

MILLENNIUM MANAGEMENT LLC: 20,385

CITADEL ADVISORS LLC: 17,690

0.21% of Pharming Group N.V. stock is owned by institutional investors.

Institutional investors have bought a total of 150.80 K shares in the last 24 months. This purchase volume represents approximately $2.41 M in transactions.